Protection against Oxidative Stress in Beta Thalassemia/Hemoglobin E Erythrocytes by Inhibitors of Glutathione Efflux Transporters

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Muanprasat, Chatchai ^a   Wongborisuth, Chokdee ^b   Pathomthongtaweechai, Nutthapoom ^a   Satitsri, Saravut ^a   Hongeng, Suradej ^b  

^a Mahidol University   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GLUTATHIONE; GLYH 101; HEMOGLOBIN E; HYDROGEN PEROXIDE; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN INHIBITOR; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; VERLUKAST;

ADOLESCENT; ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BETA THALASSEMIA; CELL LEVEL; CELL PROTECTION; CHILD; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG DETERMINATION; DRUG STRUCTURE; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; MALE; OSMOTIC STRESS; PHARMACOLOGICAL BLOCKING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCHOOL CHILD;

ADOLESCENT; ANTIOXIDANTS; BETA-THALASSEMIA; CHILD; ERYTHROCYTES; FEMALE; GLUTATHIONE; GLYCINE; HEMOGLOBIN E; HUMANS; HYDRAZINES; MALE; MEMBRANE TRANSPORT PROTEINS; OSMOTIC PRESSURE; OXIDATIVE STRESS; PROPIONATES; QUINOLINES; REACTIVE OXYGEN SPECIES; YOUNG ADULT;

EID: 84873134171     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055685     Document Type: Article

References (31)

1. Rund D, Rachmilewitz E, (1995) Advances in the pathophysiology and treatment of thalassemia. Crit Rev Oncol Hematol 20: 237-254.
2. Rund D, Rachmilewitz E, (2001) Pathophysiology of alpha- and beta-thalassemia: therapeutic implications. Semin Hematol 38: 343-349.
3. Fucharoen S, Winichagoon P, (2000) Clinical and hematologic aspects of hemoglobin E beta-thalassemia. Curr Opin Hematol 7: 106-112.
4. Fucharoen S, Winichagoon P, (2011) Haemoglobinopathies in southeast Asia. Indian J Med Res 134: 498-506.
5. Shinar E, Rachmilewitz EA, (1990) Oxidative denaturation of red blood cells in thalassemia. Semin Hematol 27: 70-82.
6. Scott MD, van den Berg JJ, Repka T, Rouyer-Fessard P, Hebbel RP, et al. (1993) Effect of excess alpha-hemoglobin chains on cellular and membrane oxidation in model beta-thalassemic erythrocytes. J Clin Invest 91: 1706-1712.
7. Origa R, Galanello R, (2011) Pathophysiology of beta thalassaemia. Pediatr Endocrinol Rev 8 Suppl 2: 263-270.
8. Ballatori N, Hammond CL, Cunningham JB, Krance SM, Marchan R, (2005) Molecular mechanisms of reduced glutathione transport: role of the MRP/CFTR/ABCC and OATP/SLC21A families of membrane proteins. Toxicol Appl Pharmacol 204: 238-255.
9. Kogan I, Ramjeesingh M, Li C, Kidd JF, Wang Y, et al. (2003) CFTR directly mediates nucleotide-regulated glutathione flux. EMBO J 22: 1981-1989.
10. Kariya C, Leitner H, Min E, van Heeckeren C, van Heeckeren A, et al. (2007) A role for CFTR in the elevation of glutathione levels in the lung by oral glutathione administration. Am J Physiol Lung Cell Mol Physiol 292: L1590-1597.
11. Day BJ, van Heeckeren AM, Min E, Velsor LW, (2004) Role for cystic fibrosis transmembrane conductance regulator protein in a glutathione response to bronchopulmonary pseudomonas infection. Infect Immun 72: 2045-2051.
12. L'Hoste S, Chargui A, Belfodil R, Duranton C, Rubera I, et al. (2009) CFTR mediates cadmium-induced apoptosis through modulation of ROS level in mouse proximal tubule cells. Free Radic Biol Med 46: 1017-1031.
13. Hirrlinger J, Konig J, Keppler D, Lindenau J, Schulz JB, et al. (2001) The multidrug resistance protein MRP1 mediates the release of glutathione disulfide from rat astrocytes during oxidative stress. J Neurochem 76: 627-636.
14. Mueller CF, Widder JD, McNally JS, McCann L, Jones DP, et al. (2005) The role of the multidrug resistance protein-1 in modulation of endothelial cell oxidative stress. Circ Res 97: 637-644.
15. Pulaski L, Jedlitschky G, Leier I, Buchholz U, Keppler D, (1996) Identification of the multidrug-resistance protein (MRP) as the glutathione-S-conjugate export pump of erythrocytes. Eur J Biochem 241: 644-648.
16. Minich T, Riemer J, Schulz JB, Wielinga P, Wijnholds J, et al. (2006) The multidrug resistance protein 1 (Mrp1), but not Mrp5, mediates export of glutathione and glutathione disulfide from brain astrocytes. J Neurochem 97: 373-384.
17. L'Hoste S, Chargui A, Belfodil R, Corcelle E, Duranton C, et al. (2010) CFTR mediates apoptotic volume decrease and cell death by controlling glutathione efflux and ROS production in cultured mice proximal tubules. Am J Physiol Renal Physiol 298: F435-453.
18. Muanprasat C, Sonawane ND, Salinas D, Taddei A, Galietta LJ, et al. (2004) Discovery of glycine hydrazide pore-occluding CFTR inhibitors: mechanism, structure-activity analysis, and in vivo efficacy. J Gen Physiol 124: 125-137.
19. Harris RR, Carter GW, Bell RL, Moore JL, Brooks DW, (1995) Clinical activity of leukotriene inhibitors. Int J Immunopharmacol 17: 147-156.
20. Kock K, Grube M, Jedlitschky G, Oevermann L, Siegmund W, et al. (2007) Expression of adenosine triphosphate-binding cassette (ABC) drug transporters in peripheral blood cells: relevance for physiology and pharmacotherapy. Clin Pharmacokinet 46: 449-470.
21. Lange T, Jungmann P, Haberle J, Falk S, Duebbers A, et al. (2006) Reduced number of CFTR molecules in erythrocyte plasma membrane of cystic fibrosis patients. Mol Membr Biol 23: 317-323.
22. Kalpravidh RW, Siritanaratkul N, Insain P, Charoensakdi R, Panichkul N, et al. (2010) Improvement in oxidative stress and antioxidant parameters in beta-thalassemia/Hb E patients treated with curcuminoids. Clin Biochem 43: 424-429.
23. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ, (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
24. Rahman I, Kode A, Biswas SK, (2006) Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nat Protoc 1: 3159-3165.
25. Weiss J, Theile D, Ketabi-Kiyanvash N, Lindenmaier H, Haefeli WE, (2007) Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by nucleoside, nucleotide, and non-nucleoside reverse transcriptase inhibitors. Drug Metab Dispos 35: 340-344.
26. Barrand MA, Winterberg M, Ng F, Nguyen M, Kirk K, et al. (2012) Glutathione export from human erythrocytes and Plasmodium falciparum malaria parasites. Biochem J 448: 389-400.
27. Freikman I, Ringel I, Fibach E, (2011) Oxidative stress-induced membrane shedding from RBCs is Ca flux-mediated and affects membrane lipid composition. J Membr Biol 240: 73-82.
28. Tesoriere L, D'Arpa D, Butera D, Allegra M, Renda D, et al. (2001) Oral supplements of vitamin E improve measures of oxidative stress in plasma and reduce oxidative damage to LDL and erythrocytes in beta-thalassemia intermedia patients. Free Radic Res 34: 529-540.
29. Amer J, Goldfarb A, Fibach E, (2004) Flow cytometric analysis of the oxidative status of normal and thalassemic red blood cells. Cytometry A 60: 73-80.
30. Cakir Y, Yildiz D, (2013) Efflux of glutathione and glutathione complexes from human erythrocytes in response to vanadate. Blood Cells Mol Dis 50: 1-7.
31. Yildiz D, Cakir Y, (2012) Efflux of glutathione and glutathione complexes from human erythrocytes in response to inorganic arsenic exposure. Biol Trace Elem Res 150: 451-459.